In rare cases, a type of Batten disease may appear at birth, write researchers in a case report, describing a…
Magdalena Kegel
Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
Abnormal processing of the trace element manganese may impact the onset or progression of Batten disease, according to a…
People with Batten disease would likely benefit from early educational interventions that allow them to make up for their lost…
Batten disease may be caused by the loss of synaptic connections between neurons in the brain, according to a study…
Yeast models of Batten disease and other lysosomal storage disorders could speed up the discovery of treatments by overcoming the…
Although Brineura (cerliponase alfa) is now approved both in Europe and the U.S. to treat CLN2 type Batten disease, its clinical trial…
Mouse experiments with a gene therapy for juvenile Batten disease indicate that lower activation of the mutated CLN3 gene are…
Patients with a specific type of Batten disease now have an approved treatment, with the U.S. Food and Drug Administration’s…